Non-Invasive Glucose Monitoring Devices Market size was valued at USD 32.95 million in 2024 and is expected to reach USD 432.42 million by 2037, expanding at around 21.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of non-invasive glucose monitoring devices is assessed at USD 39.08 million.
Extensive research associated with diabetes management globally, along with the growing investment in the development of advanced monitoring systems are expected to fuel the progress of this market in the future. The growth of the market can also be attributed to factors such as the increasing geriatric population and the rising prevalence of diabetes mellitus amongst individuals on a global level. According to the data collected from The International Diabetes Federation (IDF), in 2019, 463 million estimated number of adults aged between 20-79 years were suffering from diabetes and by 2045, the number is expected to rise to 700 million.
Growth Drivers
Challenges
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
21.9% |
Base Year Market Size (2024) |
USD 32.95 million |
Forecast Year Market Size (2037) |
USD 432.42 million |
Regional Scope |
|
The non-invasive glucose monitoring devices market is segmented based on technology into optical, transdermal, enzymatic, and others, out of which, the optical segment is anticipated to grab the largest share by the end of 2029 on account of higher positive diagnosis rates and better efficiency of this type of glucose-monitoring. Moreover, increasing government approval of glucose monitoring systems globally is also projected to contribute to the growth of the segment during the forecast period.
On the basis of modality, the wearable segment in the non-invasive glucose monitoring devices market is projected to grow with a significant CAGR over the forecast period. The growth of the segment can be attributed to the fact that patients are influenced towards needle-free and painless glucose monitoring systems. As a result, a considerable portion of the population with diabetes mellitus on a global level tend to choose wearable glucose-monitoring devices.
Based on end-user, the homecare segment held the largest share in the non-invasive glucose monitoring devices market on the back of growing advancements in connected devices in self healthcare management of diabetes mellitus. Moreover, increasing adoption of self-management devices by the individuals is further driving the market’s growth.
Our in-depth analysis of the global market includes the following segments:
By Technology |
|
By Modality |
|
By End-user |
|
Asia Pacific industry is estimated to hold largest revenue share by 2037, owing to increasing prevalence of diabetes mellitus and rising competition among major companies in the region. Furthermore, the market in North America is evaluated to occupy the largest share in terms of revenue during the forecast period, owing to the growing investment of governmental and non-governmental agencies in diabetes management research, accompanied by the presence of leading healthcare service providers in the region. Along with this, North America also leads in terms of well-established medical infrastructure that allows proper diagnosis, which is also expected to contribute to the non-invasive glucose monitoring devices market growth in the region. Alternatively, the market in Europe is also anticipated to occupy a significant share in the global non-invasive glucose-monitoring market on account of its proven success in terms of technology development and a high number of cases of diabetes mellitus in the region. As per the analysis of the Organisation for Economic Cooperation and Development (OECD), approximately 32.3 million adults in the European Union were diagnosed with diabetes in the year 2019.
Author Credits: Radhika Pawar
Copyright © 2025 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?